Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
TP53 and SF3B1 mutations in pituitary tumours